Answers are grounded in this paper and cite their sources.
Cancer therapy routinely requires Pneumocystis jiroveci prophylaxis. In those intolerant of trimethoprim/sulfamethoxazole, aerosolized pentamidine is convenient and effective. Intravenous pentamidine is often substituted in young children but its efficacy remains controversial. In this retrospective study of a large pediatric oncology cohort, we confirm intravenous pentamidine to be effective and well-tolerated as second-line prophylaxis across all ages.
No takes yet. Share an insight, caveat, or question.
Orgel et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: